Lexicon Pharmaceuticals shares are trading higher after Citigroup maintained a Buy rating on the stock and raised its price target from $6 to $8.
Portfolio Pulse from Benzinga Newsdesk
Lexicon Pharmaceuticals' stock is trading higher after Citigroup maintained a Buy rating and raised its price target from $6 to $8.
May 31, 2023 | 5:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup maintains a Buy rating on Lexicon Pharmaceuticals and raises its price target from $6 to $8, causing the stock to trade higher.
Citigroup's maintained Buy rating and increased price target for Lexicon Pharmaceuticals directly impacts the stock's short-term performance. The higher price target indicates a positive outlook for the company, leading to increased investor confidence and a higher stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100